Gyno-Daktarin Vaginal (Miconazole Nitrate)

Gyno-Daktarin Vaginal is indicated for the treatment of fungal infections that affect the vagina and surrounding tissues. It is commonly employed in clinical practice for the following purposes:

• Management of vulvovaginal candidiasis caused by susceptible Candida species.
• Relief of itching, burning, and abnormal discharge associated with yeast infections.
• Short‑term therapy to eradicate acute fungal overgrowth in the vaginal canal.
• Adjunctive use after antibiotic therapy to prevent secondary yeast infection.
• Supportive care for women experiencing recurrent mild candidal episodes, when recommended by a healthcare professional.

Side effects of Gyno-Daktarin Vaginal are generally mild, but patients should be aware of both common and less frequent reactions.

Common

• Local irritation or burning at the site of application.
• Vaginal itching or mild discomfort.
• Unpleasant odor or taste from the product.
• Slight spotting or discharge after insertion.
• Mild abdominal cramping.

Serious

• Severe allergic reaction (e.g., rash, swelling, difficulty breathing).
• Persistent or worsening vaginal irritation.
• Signs of secondary bacterial infection (e.g., fever, foul odor).
• Unusual vaginal bleeding not related to menstrual cycle.

Before using Gyno-Daktarin Vaginal, consider the following safety measures:

• Verify that the product is intended for vaginal use and that the packaging is intact.
• Do not use if you have a known hypersensitivity to miconazole, other imidazoles, or any excipients.
• Consult a healthcare professional if symptoms persist beyond the recommended treatment period.
• Avoid concurrent use of intravaginal products (e.g., douches, spermicides) unless directed by a clinician.
• Women who are pregnant, planning pregnancy, or breastfeeding should seek medical advice before initiating therapy.
• Keep the medication out of reach of children and store it at room temperature away from moisture.

Gyno-Daktarin Vaginal may interact with other substances applied to the vaginal area or absorbed systemically.

Avoid

• Simultaneous use of other intravaginal antifungal or hormonal preparations without professional guidance.
• Insertion of tampons, diaphragms, or contraceptive rings during treatment, as they may reduce drug efficacy.

Use with caution

• Systemic azole antifungals (e.g., fluconazole) that could increase overall azole exposure.
• Topical corticosteroids applied near the vagina, which may mask irritation.
• Vaginal lubricants or moisturizers that contain alcohol or irritants.
• Herbal or over‑the‑counter products that claim antifungal activity, pending clinician review.